News and Comments


  Wednesday, December 18, 2013

When Amgen (AMGN) develops a drug, the wise King does whatever it takes to squeeze every drop of its therapeutic capability before submitting the new drug application (NDA) to the FDA for approval. The firm is rich in its science, scientists, pipeline of investigational products and its approved products. All the problems the firm encountered that analysts believed would erode its fortune, such as limiting the use of its growth factors did not impact the firm’s growth, but unveiled the character and culture that made the king deserve its throne.   More...


  Monday, December 09, 2013

Taking down Gilead (GILD) seems to be beyond the reach authors of tales intended to frighten investors into selling this outstanding stock. The attempts have been repetitive but short of success. Gilead is a stallion. Unlike stallions, the horses whose muscular superiority over other horses is genetically derived, Gilead’s power is acquired through a unique culture that embraces the power of intuition, self-confidence, common sense and courage. Using an optimal amount of faith, the firm turned intuition into inspiration and using courage and wisdom, the Stallion carried out inspired tasks fated unattainable by others.  More...

Recent Postings



Intrexon (XON) Valeant Pharmaceuticals International (VRX) ISIS (ISIS) Aimmune Therapeutics (AIMT) GUARDIAN HEALTH Anadys (ANDS) Merck (MRK) Array Pharmaceuticals (ARRY) Ziofpharm (ZIOP) Bristol-Myers Squibb (BMY) CompuGen (CGEN) TOKAI (TKAOI) Illumina (ILMN) NOVOCURE (NVCR) Abbott Laboratories (ABT) Prolor Biotech (PBTH) Sequenom (SQNM) REGULUS (RGLS) Adaptimmune (ADAP) KITE (KITE) Dendreon (DNDN) Jazz Pharmaceuticals (JAZZ) Seattle Genetics (SGEN) Vitae Pharmaceuticals (VTAE) Multiple Myeloma Elan (ELN) ARGOS (ARGS) Cytokinetics (CYTK) Sanofi (SNA) Global Cell Therapeutics (GBT) Bellicum (BLCM) Ariad (ARIA) Ridaforolimus Mirati Therapeutics (MRTX) Biocryst (BCRX) Sarepta (SRPT) Intercept (ICPT) Onyx (ONXX) Benlysta (belimumab) Xoma (XOMA) Zerenex Sanofi (SNY) Spike Therapeutics (ONCE) KERYX (KERX) SUNESIS PHARMACEUTICALS (SNSS) Sangamo (SGMO) NANTKWEST (NK) Dynavax (DVAX) JUNO (JUNO) Rapamune Theravance (THRX) Human Longevity (HLI) Sanofi-Aventis (SAN) BIOMARIN (BMRN) Amgen (AMGN) AGOS (ARGS) Intermune (ITMN) Ionis (IONS) Endometrial Cancer SYNTA (SNTA) INNOVIVA (INVA) C4 Therapeutics Agenus (AGEN HALOZYME (HALO) Anacor (ANAC) Roche (RHHBY) NEKTAR (NKTR)) Advaxis (ADXS) AstraZeneca (AZN) AERIE PHARMACEUTICALS ACADIA (ACAD) ImmunoGen (IMGN) Telaprevir Idenix (IDIX) SERES THERAPEUTICS (MCRB) Vertex (VRTX) Revlimid (lenolidamide) Human Genome Sciences (HGSI) IDERA (IDRA) Trastuzumab-DM1 Theravance Bio Pharma (TBPH) Editas (EDIT) Velcade (bortezomib) ADVENTRIX (ANX) Regeneron (REGN) Herceptin OSI (OSIP) Prosensa (RNA) Exelixis (EXEL) Incyte (INCY) Gilead (GILD) GlaxoSmithKline (GSK) VANDA (VNDA) Alder Biopharmaceuticals (ALDR) Alnylam (ALNY) galapagos (GLPG) RenenxBio (RGNX) Roche (ROCHE) ARCA (ABIO) Biogen Idec (BIIB) MODERNA ZALTRAP™ Pluristem (PSTI) Auspex (ASPX) Inovio (INO) PTC Therapeutics (PTCT) Agenus (AGEN) ABBVIE (ABBV) Micromet (MITI) Genentech Tysabri Galena (GALE)